Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Canadian (TSX) Pharma Industry Analysis

UpdatedNov 14, 2025
DataAggregated Company Financials
Companies60
  • 7D-14.5%
  • 3M-18.9%
  • 1Y-22.7%
  • YTD-14.8%

Last week, the Pharma industry hasn't moved much but Curaleaf Holdings is up 4.9% in that time. Unfortunately though, the industry is down 12% over the past 12 months. Earnings are forecast to grow by 62% annually.

Industry Valuation and Performance

Has the Canadian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 15 Nov 2025CA$15.5bCA$11.3b-CA$1,866,913,276.1515.6x-8.3x1.4x
Mon, 13 Oct 2025CA$17.2bCA$11.3b-CA$2,040,987,138.2035.1x-8.4x1.5x
Wed, 10 Sep 2025CA$17.0bCA$11.2b-CA$2,035,900,083.7238.1x-8.4x1.5x
Fri, 08 Aug 2025CA$12.5bCA$11.8b-CA$2,564,822,923.4718.2x-4.9x1.1x
Sun, 06 Jul 2025CA$10.1bCA$11.7b-CA$2,527,776,876.4717.2x-4x0.9x
Tue, 03 Jun 2025CA$9.8bCA$11.7b-CA$2,517,617,470.0519.4x-3.9x0.8x
Thu, 01 May 2025CA$10.5bCA$11.9b-CA$2,501,480,895.9320.9x-4.2x0.9x
Sat, 29 Mar 2025CA$10.5bCA$12.3b-CA$2,594,338,733.3519.5x-4x0.9x
Mon, 24 Feb 2025CA$12.0bCA$12.1b-CA$2,216,892,701.0621.8x-5.4x1x
Wed, 22 Jan 2025CA$12.6bCA$12.1b-CA$2,409,230,307.5728.9x-5.2x1x
Fri, 20 Dec 2024CA$12.6bCA$12.1b-CA$2,600,855,126.3719.4x-4.8x1x
Sun, 17 Nov 2024CA$14.9bCA$12.0b-CA$2,653,132,502.2016.2x-5.6x1.2x
Tue, 15 Oct 2024CA$18.4bCA$11.8b-CA$2,699,739,851.4518.1x-6.8x1.6x
Thu, 12 Sep 2024CA$18.0bCA$11.6b-CA$2,700,699,947.5520.5x-6.7x1.6x
Sat, 10 Aug 2024CA$19.3bCA$11.7b-CA$2,648,771,519.6723.6x-7.3x1.6x
Mon, 08 Jul 2024CA$19.0bCA$11.7b-CA$3,191,241,919.1818.5x-6x1.6x
Wed, 05 Jun 2024CA$20.9bCA$11.7b-CA$2,744,782,781.5213x-7.6x1.8x
Fri, 03 May 2024CA$25.2bCA$11.8b-CA$3,422,844,135.8311.7x-7.4x2.1x
Sun, 31 Mar 2024CA$25.0bCA$11.9b-CA$3,482,675,772.549.3x-7.2x2.1x
Tue, 27 Feb 2024CA$22.5bCA$12.0b-CA$4,647,759,588.679.5x-4.8x1.9x
Thu, 25 Jan 2024CA$21.0bCA$12.4b-CA$6,769,620,806.009.6x-3.1x1.7x
Sat, 23 Dec 2023CA$17.0bCA$12.2b-CA$6,715,146,418.008.6x-2.5x1.4x
Mon, 20 Nov 2023CA$18.0bCA$12.5b-CA$6,837,871,349.007.1x-2.6x1.4x
Wed, 18 Oct 2023CA$18.7bCA$12.4b-CA$7,330,037,148.0013.3x-2.5x1.5x
Fri, 15 Sep 2023CA$21.7bCA$12.9b-CA$7,891,240,783.0015.1x-2.7x1.7x
Sun, 13 Aug 2023CA$14.2bCA$13.1b-CA$8,044,261,319.0011.9x-1.8x1.1x
Tue, 11 Jul 2023CA$16.4bCA$13.2b-CA$9,521,691,924.0012.8x-1.7x1.2x
Thu, 08 Jun 2023CA$14.6bCA$13.3b-CA$10,398,674,708.0010.3x-1.4x1.1x
Sat, 06 May 2023CA$16.5bCA$13.3b-CA$10,297,242,673.0011.1x-1.6x1.2x
Mon, 03 Apr 2023CA$16.3bCA$13.4b-CA$10,036,187,625.008.7x-1.6x1.2x
Wed, 01 Mar 2023CA$19.3bCA$13.7b-CA$10,254,161,221.009.8x-1.9x1.4x
Fri, 27 Jan 2023CA$19.0bCA$13.5b-CA$10,087,001,268.0014.4x-1.9x1.4x
Sun, 25 Dec 2022CA$20.0bCA$13.6b-CA$10,151,710,113.0012.4x-2x1.5x
Tue, 22 Nov 2022CA$29.1bCA$13.5b-CA$10,230,610,337.0010.4x-2.8x2.2x
Price to Earnings Ratio

-2.8x


Total Market Cap: CA$29.1bTotal Earnings: -CA$10,230,610,337.00Total Revenue: CA$13.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Pharma Industry Price to Earnings3Y Average -4.4x202320242025
Current Industry PE
  • Investors are relatively neutral on the Canadian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 1.4x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 5.5% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Canadian Healthcare industry?

CA Market1.57%
Healthcare-6.53%
Pharma-14.51%
Pharma-14.51%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SKNY LIR Life SciencesCA$0.58-52.5%
CA$9.8m		n/an/a
RAMM RAMM PharmaCA$0.09500.0%
+CA$9.0m		800.0%PS2.8x
GUD Knight TherapeuticsCA$6.141.5%
+CA$8.9m		18.3%PS1.5x
GSD Devonian Health GroupCA$0.2033.3%
+CA$8.3m		53.8%PS1.1x
XLY Auxly Cannabis GroupCA$0.163.2%
+CA$6.7m		357.1%PE7.7x

Latest News

GTII
CA$8.00
Green Thumb Industries
7D
-18.5%
1Y
-41.0%
VREO
CA$0.65
Vireo Growth
7D
-18.8%
1Y
4.8%
CURA
CA$2.89
Curaleaf Holdings
7D
-22.3%
1Y
-7.7%
SKNY
CA$0.58
LIR Life Sciences
7D
-52.5%
1Y
n/a
XLY
CA$0.16
Auxly Cannabis Group
7D
3.2%
1Y
357.1%

Auxly Cannabis Group Inc. (TSE:XLY) Stocks Shoot Up 38% But Its P/S Still Looks Reasonable

Nov 12
Auxly Cannabis Group Inc. (TSE:XLY) Stocks Shoot Up 38% But Its P/S Still Looks Reasonable
TRUL
CA$7.37
Trulieve Cannabis
7D
-20.3%
1Y
-22.8%
WEED
CA$1.51
Canopy Growth
7D
-8.5%
1Y
-71.1%

WEED: Rising Discount Rate Will Pressure Share Price In The Months Ahead

Analysts have adjusted their price target for Canopy Growth downward from $2.64 to $1.30. They cited an increased discount rate as well as ongoing evaluations of profit margin and future earnings potential.
CL
CA$1.32
Cresco Labs
7D
-13.2%
1Y
-33.0%
TSND
CA$0.57
TerrAscend
7D
-40.0%
1Y
-55.1%

Earnings Release: Here's Why Analysts Cut Their TerrAscend Corp. (TSE:TSND) Price Target To CA$1.75

Nov 09
Earnings Release: Here's Why Analysts Cut Their TerrAscend Corp. (TSE:TSND) Price Target To CA$1.75
GUD
CA$6.14
Knight Therapeutics
7D
1.5%
1Y
18.3%
VRNO
CA$1.33
Verano Holdings
7D
-19.4%
1Y
-43.9%
RAMM
CA$0.09
RAMM Pharma
7D
500.0%
1Y
800.0%
CRDL
CA$1.44
Cardiol Therapeutics
7D
2.9%
1Y
-43.3%
GSD
CA$0.20
Devonian Health Group
7D
33.3%
1Y
53.8%
ALGO
CA$0.26
Light AI
7D
27.5%
1Y
n/a
OPTI
CA$0.36
Optimi Health
7D
12.3%
1Y
82.5%